136 related articles for article (PubMed ID: 38125298)
1. Cluster-based radiomics reveal spatial heterogeneity of bevacizumab response for treatment of radiotherapy-induced cerebral necrosis.
Tan HQ; Cai J; Tay SH; Sim AYL; Huang L; Chua MLK; Tang Y
Comput Struct Biotechnol J; 2024 Dec; 23():43-51. PubMed ID: 38125298
[TBL] [Abstract][Full Text] [Related]
2. A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy.
Cai J; Zheng J; Shen J; Yuan Z; Xie M; Gao M; Tan H; Liang Z; Rong X; Li Y; Li H; Jiang J; Zhao H; Argyriou AA; Chua MLK; Tang Y
Clin Cancer Res; 2020 Oct; 26(20):5438-5447. PubMed ID: 32727886
[TBL] [Abstract][Full Text] [Related]
3. A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Zhuo X; Zhao H; Chen M; Mu Y; Li Y; Cai J; Li H; Xu Y; Tang Y
Radiat Oncol; 2023 Mar; 18(1):43. PubMed ID: 36859353
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
5. Nomogram Based on Clinical and Radiomics Data for Predicting Radiation-induced Temporal Lobe Injury in Patients with Non-metastatic Stage T4 Nasopharyngeal Carcinoma.
Bin X; Zhu C; Tang Y; Li R; Ding Q; Xia W; Tang Y; Tang X; Yao D; Tang A
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e482-e492. PubMed ID: 36008245
[TBL] [Abstract][Full Text] [Related]
6. A MRI-based radiomics model predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
Bao D; Zhao Y; Li L; Lin M; Zhu Z; Yuan M; Zhong H; Xu H; Zhao X; Luo D
Eur Radiol; 2022 Oct; 32(10):6910-6921. PubMed ID: 35639143
[TBL] [Abstract][Full Text] [Related]
7. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
8. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
[TBL] [Abstract][Full Text] [Related]
9. Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics.
Keek SA; Beuque M; Primakov S; Woodruff HC; Chatterjee A; van Timmeren JE; Vallières M; Hendriks LEL; Kraft J; Andratschke N; Braunstein SE; Morin O; Lambin P
Front Oncol; 2022; 12():920393. PubMed ID: 35912214
[TBL] [Abstract][Full Text] [Related]
10. An investigation of machine learning methods in delta-radiomics feature analysis.
Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics.
Yang Y; Wu J; Mai W; Li H
Contrast Media Mol Imaging; 2022; 2022():3417480. PubMed ID: 36226269
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
Xu Y; Rong X; Hu W; Huang X; Li Y; Zheng D; Cai Z; Zuo Z; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1087-1095. PubMed ID: 29885994
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Prediction of Adaptive Radiation Therapy Eligibility Using MRI-Based Radiomics for Advanced Nasopharyngeal Carcinoma Patients.
Yu TT; Lam SK; To LH; Tse KY; Cheng NY; Fan YN; Lo CL; Or KW; Chan ML; Hui KC; Chan FC; Hui WM; Ngai LK; Lee FK; Au KH; Yip CW; Zhang Y; Cai J
Front Oncol; 2019; 9():1050. PubMed ID: 31681588
[No Abstract] [Full Text] [Related]
15. Predicting response to radiotherapy of head and neck squamous cell carcinoma using radiomics from cone-beam CT images.
Sellami S; Bourbonne V; Hatt M; Tixier F; Bouzid D; Lucia F; Pradier O; Goasduff G; Visvikis D; Schick U
Acta Oncol; 2022 Jan; 61(1):73-80. PubMed ID: 34632924
[TBL] [Abstract][Full Text] [Related]
16. Blood-Brain Barrier Repair of Bevacizumab and Corticosteroid as Prediction of Clinical Improvement and Relapse Risk in Radiation-Induced Brain Necrosis: A Retrospective Observational Study.
Xue R; Chen M; Cai J; Deng Z; Pan D; Liu X; Li Y; Rong X; Li H; Xu Y; Shen Q; Tang Y
Front Oncol; 2021; 11():720417. PubMed ID: 34692494
[TBL] [Abstract][Full Text] [Related]
17. Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach.
Kim JP; Kim J; Jang H; Kim J; Kang SH; Kim JS; Lee J; Na DL; Kim HJ; Seo SW; Park H
Sci Rep; 2021 Mar; 11(1):6954. PubMed ID: 33772041
[TBL] [Abstract][Full Text] [Related]
18. Natural Changes in Radiological and Radiomics Features on MRIs of Soft-Tissue Sarcomas Naïve of Treatment: Correlations With Histology and Patients' Outcomes.
Fadli D; Kind M; Michot A; Le Loarer F; Crombé A
J Magn Reson Imaging; 2022 Jul; 56(1):77-96. PubMed ID: 34939705
[TBL] [Abstract][Full Text] [Related]
19. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to preoperative neoadjuvant chemotherapy in extremity high-grade osteosarcoma using X-ray and multiparametric MRI radiomics.
Luo Z; Li J; Liao Y; Huang W; Li Y; Shen X
J Xray Sci Technol; 2023; 31(3):611-626. PubMed ID: 37005907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
